Literature DB >> 2857869

Cisapride in cystic fibrosis.

J E Prinsen, M Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2857869     DOI： 10.1016/s0140-6736(85)92106-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Gastrointestinal complications in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

Review 2.  Gastrointestinal tract and nutrition in cystic fibrosis: pathophysiology.

Authors:  J A Dodge
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

Review 3.  Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.

Authors:  R W McCallum; C Prakash; D M Campoli-Richards; K L Goa
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

4.  Electrogastrography in children with cystic fibrosis.

Authors:  Atiye Nur Aktay; Mark L Splaingard; Tami Miller; Mary Ellen Freeman; Heidi Hoeppner; Steven L Werlin
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

Review 5.  Rational pharmacotherapy of gastrointestinal motility disorders.

Authors:  P Demol; H J Ruoff; T R Weihrauch
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

6.  New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up.

Authors:  A Malfroot; I Dab
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

Review 7.  Drug therapies for reducing gastric acidity in people with cystic fibrosis.

Authors:  Sze May Ng; Helen S Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-08-22

8.  Drug therapies for reducing gastric acidity in people with cystic fibrosis.

Authors:  Sze May Ng; Helen S Moore
Journal:  Cochrane Database Syst Rev       Date:  2021-04-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.